UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000045874
Receipt number R000051645
Scientific Title Evaluation after taking Ninjinyoeito in the treatment of post-treatment malaise associated with gynecological cancer: an prospective observational study
Date of disclosure of the study information 2021/10/26
Last modified on 2021/10/26 16:27:17

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Observation of the effect of Ninjinyoeito on post-treatment malaise in gynecological cancer

Acronym

Observation of the effect of Ninjinyoeito on post-treatment malaise in gynecological cancer

Scientific Title

Evaluation after taking Ninjinyoeito in the treatment of post-treatment malaise associated with gynecological cancer: an prospective observational study

Scientific Title:Acronym

Evaluation after taking Ninjinyoeito in the treatment of post-treatment malaise associated with gynecological cancer: an prospective observational study

Region

Japan


Condition

Condition

Malaise

Classification by specialty

Obstetrics and Gynecology

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

To investigate the improvement of post-treatment malaise in gynecological cancer patients by administration of Ninjinyoeito

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

The amount of change, rate of change of the CFS score 12 weeks after the dosage start

Key secondary outcomes

1) Amount and rate of change in evaluation forms (ECOG-PS, HADS, AIS, The FAACT A/CS)
2) Amount and rate of change of laboratory values measured in routine clinical care at the time of patient visit
3) Amount and rate of change in oxidative stress and antioxidant capacity
4) Associations between insomnia, loss of appetite, and anxiety and improvement in fatigue


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit


Not applicable

Age-upper limit


Not applicable

Gender

Female

Key inclusion criteria

1) The patients complaining of fatigue and malaise
2 ) The patients who have completed gynecological cancer (cervical cancer, uterine cancer, ovarian cancer) treatment (surgical operation (pelvic lymph node dissection), chemotherapy, radiotherapy) for more than one month.
3) The patients who were prescribed with Ninjinyoeito under a doctor's diagnosis
4) The patients with documented consent

Key exclusion criteria

1) The patients who are regularly using other Kampo medicine.
2) The patients with stage IV malignancy
3) The patients with PS(Performance Status) of 3 or 4
4) The patients considered to have a prognosis of less than six months
5) The patients with the experience an allergy after taking any Kampo medicine
6) The patients with a remarkable digestive organ symptom
7) The patients diagnosed with major depressive disorder and undergoing prescription adjustment
8) The patients with aldosteronism, myopathy, hypokalemia, or suspected
9) The patients with hepatic dysfunction (AST>80 IU/L or ALT>80 IU/L)
10) The patients who were judged not to be included by researchers

Target sample size

30


Research contact person

Name of lead principal investigator

1st name Masaru
Middle name
Last name Mimura

Organization

Keio University School of Medicine

Division name

Center for Kampo Medicine

Zip code

160-8582

Address

SHINANOMACHI 35, SHINJYUKU-KU, TOKYO JAPAN

TEL

03-5366-3824

Email

mimura@a7.keio.jp


Public contact

Name of contact person

1st name Yuko
Middle name
Last name Horiba

Organization

Keio University School of Medicine

Division name

Center for Kampo Medicine

Zip code

160-8582

Address

SHINANOMACHI 35, SHINJYUKU-KU, TOKYO JAPAN

TEL

03-5366-3824

Homepage URL


Email

mannta217@keio.jp


Sponsor or person

Institute

Keio University School of Medicine
Center for Kampo Medicine

Institute

Department

Personal name



Funding Source

Organization

None

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Keio University School of Medicine

Address

SHINANOMACHI 35, SHINJYUKU-KU, TOKYO JAPAN 160-8582

Tel

03-5363-3503

Email

med-rinri-jimu@adst.keio.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

慶應義塾大学病院(東京都)


Other administrative information

Date of disclosure of the study information

2021 Year 10 Month 26 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Enrolling by invitation

Date of protocol fixation

2021 Year 08 Month 03 Day

Date of IRB

2021 Year 08 Month 10 Day

Anticipated trial start date

2021 Year 08 Month 10 Day

Last follow-up date

2022 Year 12 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

CFS
ECOG-PS
HADS
AIS
The FAACT A/CS questionnaire


Management information

Registered date

2021 Year 10 Month 26 Day

Last modified on

2021 Year 10 Month 26 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000051645